Layla vs Luvo Health
Two GLP-1 providers, one scorecard. Both are graded on the same six Desk Score dimensions — here is how they stack up, and which one fits you.
Desk Score
People wanting oral or injectable semaglutide with a brand-inclusive glp-1 upgrade path.
- semaglutide
- $237/mo
- tirzepatide
- $199/mo
Before enrolling
Brand-inclusive GLP-1 program is expensive, starting around 1,299 dollars
Desk Score
Shoppers who want compounded and brand GLP-1s and an oral tablet option with the four-week price visible up front, and who will get any longer plan's total and refund rule in writing before committing.
- semaglutide
- $209 per 4 weeks
- tirzepatide
- $249 per 4 weeks
Before enrolling
The longer-plan prices are no longer published — the pricing page shows a range per program and says plans run from 4 to 24 weeks, so the cost of committing cannot be read before the intake
Our review of Luvo Health gives it 81/100 (B−), while our review of Layla gives it 70/100 (C). The score breakdown shows where each provider does better.
Desk Score, dimension by dimension
Same six measured dimensions for both. The green bar marks the stronger score. See the methodology.
70/100
C
81/100
B−
The spec sheet
Check the billing terms before comparing the figures. Our guide to paying for GLP-1 care without insurance explains how medication charges, membership fees and prepaid terms affect what you owe.
| Field | Layla | Luvo Health |
|---|---|---|
| Semaglutide | $237/moFull plan terms$237/mo (all doses, compounded) | $209 per 4 weeksFull plan terms$209 per 4 weeks injection; $259 per 4 weeks tablets (compounded; billed every 28 days; 50% off the first 4 weeks, $104.50 injection or $129.50 tablets; plans from 4 to 24 weeks, longer-plan prices not published) |
| Tirzepatide | $199/moFull plan terms$199/mo (all doses, compounded) | $249 per 4 weeksFull plan terms$249 per 4 weeks injection (compounded; billed every 28 days; 50% off the first 4 weeks, $124.50; plans from 4 to 24 weeks, longer-plan prices not published) |
| Coverage | Not confirmed for Layla. | All 50 states plus Washington D.C. per its terms (some services may vary by state; no state list published) |
| Brand-name | Brand-name option listed | Brand-name option listed |
| Oral option | Oral option listed | Oral option listed |
| Best for | People wanting oral or injectable semaglutide with a brand-inclusive glp-1 upgrade path. | Shoppers who want compounded and brand GLP-1s and an oral tablet option with the four-week price visible up front, and who will get any longer plan's total and refund rule in writing before committing. |
| Desk Score | 70/100C | 81/100B− |
The verdict
Desk pick — Luvo HealthLuvo Health has the higher Desk Score, but Layla may be a better fit if it covers your state, offers the prescribed product or has billing terms that work better for you.
People wanting oral or injectable semaglutide with a brand-inclusive glp-1 upgrade path.
Shoppers who want compounded and brand GLP-1s and an oral tablet option with the four-week price visible up front, and who will get any longer plan's total and refund rule in writing before committing.
CoreAge Rx leads the whole ranking at 94/100
Whichever of these two you lean toward, our #1-rated provider outscores them both. Both compounded injections with dose-independent advertised rates. The $79 and $129 monthly equivalents require a year paid in full; confirm the total charge and refund terms.
More head-to-heads
- CoreAge Rx vs Layla
- CoreAge Rx vs Luvo Health
- Layla vs RxSpan MD
- Luvo Health vs RxSpan MD
- Layla vs Shed
- He & She MD vs Luvo Health
Or see the full comparison hub and the complete ranking.